Review
36 Quigg RJ. Complement and autoimmune glomerular diseases. Curr Dir Autoimmun 2004;7:165–80. 37 Noronha IL, Fujihara CK, Zatz R. The inflammatory component in progressive renal disease--are interventions possible? Nephrol Dial Transplant 2002;17:363–8. 38 Belmont HM, Buyon J, Giorno R, et al . Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994;37:376–83. 39 Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med 2017;23:279–87. 40 Chirivi RGS, van Rosmalen JWG, van der Linden M, et al . Therapeutic AcpA inhibits net formation: a potential therapy for neutrophil-mediated inflammatory diseases. Cell Mol Immunol 2021;18:1528–44. 41 Seredkina N, Zykova SN, Rekvig OP. Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis. Am J Pathol 2009;175:97–106. 42 Zykova SN, Tveita AA, Rekvig OP. Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. PLoS One 2010;5:e12096. 43 Miyata T, Inagi R, Nangaku M, et al . Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J Clin Invest 2002;109:585–93. 44 Alexander JJ, Pickering MC, Haas M, et al . Complement factor H limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. J Am Soc Nephrol 2005;16:52–7. 45 Trendelenburg M, Fossati-Jimack L, Cortes-Hernandez J, et al . The role of complement in cryoglobulin-induced immune complex glomerulonephritis. J Immunol 2005;175:6909–14. 46 Moiseev S, Lee JM, Zykova A, et al . The alternative complement pathway in ANCA- associated vasculitis: further evidence and a meta-analysis. Clin Exp Immunol 2020;202:394–402. 47 Falk RJ, Jennette JC. Immune complex induced glomerular lesions in C5 sufficient and deficient mice. Kidney Int 1986;30:678–86. 48 Sheerin NS, Abe K, Risley P, et al . Accumulation of immune complexes in glomerular disease is independent of locally synthesized C3. J Am Soc Nephrol 2006;17:686–96. 49 Crnogorac M, Horvatic I, Kacinari P, et al . Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome. J Nephrol 2018;31:257–62. 50 Kronbichler A, Shin JI, Lee KH, et al . Clinical associations of renal involvement in ANCA-associated vasculitis. Autoimmun Rev 2020;19:102495. 51 Oba R, Kanzaki G, Sasaki T, et al . Long-Term renal survival in antineutrophil cytoplasmic antibody-associated glomerulonephritis with complement C3 deposition. Kidney Int Rep 2021;6:2661–70. 52 Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998;279:1052–4. 53 Parodis I, Tamirou F, Houssiau FA. Prediction of prognosis and renal outcome in lupus nephritis. Lupus Sci Med 2020;7:e000389. 54 Dumont C, Mérouani A, Ducruet T, et al . Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 2020;35:843–50. 55 LeBleu VS, Teng Y, O’Connell JT, et al . Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 2013;19:227–31. 56 Chapman GB, Farrah TE, Chapman FA, et al . Utility of interval kidney biopsy in ANCA- associated vasculitis. Rheumatology 2022;61:1966–74. 57 Morales E, Trujillo H, Bada T, et al . What is the value of repeat kidney biopsies in patients with lupus nephritis? Lupus 2021;30:25–34. 58 Parikh SV, Malvar A, Song H, et al . Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis. Kidney Int 2022;102:845–65. 59 Arazi A, Rao DA, Berthier CC, et al . The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol 2019;20:902–14. 60 Frangou E, Garantziotis P, Grigoriou M, et al . Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis. Ann Rheum Dis 2022;81:1409–19. 61 Chen Y, Huang S, Chen T, et al . Machine learning for prediction and risk stratification of lupus nephritis renal flare. Am J Nephrol 2021;52:152–60. 62 Zickert A, Lannfelt K, Schmidt Mende J, et al . Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment. Rheumatology 2021;60:3443–50. 63 Vindebro R, Spoerry C, von Pawel-Rammingen U. Rapid IgG heavy chain cleavage by the streptococcal IgG endopeptidase ides is mediated by ides monomers and is not due to enzyme dimerization. FEBS Lett 2013;587:1818–22. 64 Yang R, Otten MA, Hellmark T, et al . Successful treatment of experimental glomerulonephritis with ides and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant 2010;25:2479–86. 65 Uhlin F, Szpirt W, Kronbichler A, et al . Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study. J Am Soc Nephrol 2022;33:829–38.
6 Ge Y, Jiang C, Sung S-SJ, et al . Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J Exp Med 2013;210:2387–401. 7 Hakkim A, Fürnrohr BG, Amann K, et al . Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 2010;107:9813–8. 8 Fanouriakis A, Tziolos N, Bertsias G, et al . Update ο n the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 2021;80:14–25. 9 Bajema IM, Wilhelmus S, Alpers CE, et al . Revision of the International Society of Nephrology/Renal pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of health activity and chronicity indices. Kidney Int 2018;93:789–96. 10 Kudose S, Santoriello D, Bomback AS, et al . Sensitivity and specificity of pathologic findings to diagnose lupus nephritis. Clin J Am Soc Nephrol 2019;14:1605–15. 11 Rijnink EC, Teng YKO, Wilhelmus S, et al . Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis. Clin J Am Soc Nephrol 2017;12:734–43. 12 Bolognesi MM, Capitoli G, Galimberti S, et al . Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV. Ann Rheum Dis 2022;81:1704–11. 13 Lusco MA, Fogo AB, Najafian B, et al . AJKD atlas of renal pathology: membranous lupus nephritis, ISN/RPS class V. Am J Kidney Dis 2017;70:e13–15. 14 Ravindran A, Casal Moura M, Fervenza FC, et al . In patients with membranous lupus nephritis, Exostosin-Positivity and Exostosin-Negativity represent two different phenotypes. J Am Soc Nephrol 2021;32:695–706. 15 Caza TN, Hassen SI, Kuperman M, et al . Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int 2021;100:171–81. 16 Muchtar E, Magen H, Gertz MA. How I treat cryoglobulinemia. Blood 2017;129:289–98. 17 Chen Y-P, Cheng H, Rui H-L, et al . Cryoglobulinemic vasculitis and glomerulonephritis: concerns in clinical practice. Chin Med J 2019;132:1723–32. 18 Kiremitci S, Calayoglu R, Ensari A, et al . Pathologist’s puzzle: membranoproliferative glomerulonephritis-like features in cryoglobulinemic glomerulonephritis. Pathol Res Pract 2012;208:254–8. 19 Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture’s disease (anti- GBM). J Autoimmun 2014;48-49:108–12. 20 McAdoo SP, Pusey CD. Anti-Glomerular basement membrane disease. Clin J Am Soc Nephrol 2017;12:1162–72. 21 Levy JB, Turner AN, Rees AJ, et al . Long-Term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001;134:1033–42. 22 van Daalen EE, Jennette JC, McAdoo SP, et al . Predicting outcome in patients with anti-GBM glomerulonephritis. Clin J Am Soc Nephrol 2018;13:63–72. 23 Shin JI, Geetha D, Szpirt WM, et al . Anti-Glomerular basement membrane disease (Goodpasture disease): from pathogenesis to plasma exchange to ides. Ther Apher Dial 2022;26:24–31. 24 Trivioli G, Gopaluni S, Urban ML, et al . Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome. Clin Kidney J 2021;14:332–40. 25 Geetha D, Jefferson JA. Anca-Associated vasculitis: core curriculum 2020. Am J Kidney Dis 2020;75:124–37. 26 Lindquist JA, Hildebrandt J, Philipsen L, et al . Immune complexes and complexity: investigating mechanisms of renal disease. Int Urol Nephrol 2017;49:735–9. 27 Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004;65:2145–52. 28 Lin W, Shen C, Zhong Y, et al . Glomerular immune deposition in MPO-ANCA associated glomerulonephritis is associated with poor renal survival. Front Immunol 2021;12:625672. 29 Hilhorst M, van Paassen P, van Rie H, et al . Complement in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2017;32:1302–13. 30 Gou S-J, Yuan J, Wang C, et al . Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN. Clin J Am Soc Nephrol 2013;8:1884–91. 31 Villacorta J, Diaz-Crespo F, Acevedo M, et al . Glomerular C3d as a novel prognostic marker for renal vasculitis. Hum Pathol 2016;56:31–9. 32 Abrass CK, Nies KM, Louie JS, et al . Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 1980;23:273–82. 33 Roccatello D, Saadoun D, Ramos-Casals M, et al . Cryoglobulinaemia. Nat Rev Dis Primers 2018;4:11. 34 Hilhorst M, van Paassen P, van Breda Vriesman P, et al . Immune complexes in acute adult-onset Henoch-Schonlein nephritis. Nephrol Dial Transplant 2011;26:3960–7. 35 Kojima T, Inoue D, Wajima T, et al . Circulating immune-complexes and complement activation through the classical pathway in myeloperoxidase-ANCA-associated glomerulonephritis. Ren Fail 2022;44:714–23.
Kronbichler A, et al . Ann Rheum Dis 2023; 82 :585–593. doi:10.1136/annrheumdis-2022-222495
592
Powered by FlippingBook